Marshall Wace’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-17,552
| Closed | -$206K | – | 2842 |
|
2025
Q1 | $206K | Buy |
+17,552
| New | +$206K | ﹤0.01% | 2266 |
|
2024
Q4 | – | Sell |
-9,980
| Closed | -$419K | – | 2664 |
|
2024
Q3 | $419K | Sell |
9,980
-31,467
| -76% | -$1.32M | ﹤0.01% | 1836 |
|
2024
Q2 | $1.51M | Buy |
41,447
+11,229
| +37% | +$409K | ﹤0.01% | 1361 |
|
2024
Q1 | $1.54M | Buy |
+30,218
| New | +$1.54M | ﹤0.01% | 1285 |
|
2021
Q4 | – | Sell |
-971
| Closed | -$140K | – | 3442 |
|
2021
Q3 | $140K | Buy |
+971
| New | +$140K | ﹤0.01% | 2250 |
|
2020
Q4 | – | Sell |
-6,198
| Closed | -$1.49M | – | 1945 |
|
2020
Q3 | $1.49M | Buy |
+6,198
| New | +$1.49M | 0.01% | 858 |
|
2018
Q4 | – | Sell |
-1,628
| Closed | -$95K | – | 1728 |
|
2018
Q3 | $95K | Buy |
+1,628
| New | +$95K | ﹤0.01% | 1098 |
|
2016
Q1 | – | Sell |
-2,027
| Closed | -$506K | – | 1141 |
|
2015
Q4 | $506K | Buy |
+2,027
| New | +$506K | ﹤0.01% | 803 |
|